ACA
BSX icon

Aptus Capital Advisors’s Boston Scientific BSX Stock Holding History

Aptus Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Sell
5,594
-1,628
-23% -$88.4K ﹤0.01% 1043
2026
Q1 		$453K Sell
7,222
-70,813
-91% -$5.66M ﹤0.01% 741
2025
Q4 		$7.44M Buy
78,035
+2,173
+3% +$213K 0.05% 263
2025
Q3 		$7.41M Buy
75,862
+63,382
+508% +$6.56M 0.05% 255
2025
Q2 		$1.34M Buy
12,480
+1,098
+10% +$111K 0.01% 479
2025
Q1 		$1.15M Sell
11,382
-310
-3% -$31.2K 0.01% 485
2024
Q4 		$1.04M Buy
11,692
+1,723
+17% +$152K 0.01% 495
2024
Q3 		$835K Buy
9,969
+520
+6% +$41K 0.01% 444
2024
Q2 		$728K Buy
9,449
+1,639
+21% +$120K 0.01% 440
2024
Q1 		$535K Buy
7,810
+1,149
+17% +$73.9K 0.01% 499
2023
Q4 		$385K Buy
6,661
+142
+2% +$7.58K 0.01% 426
2023
Q3 		$344K Buy
+6,519
New +$342K 0.01% 447
2022
Q4 		– Sell
-64,563
Closed -$2.5M – 805
2022
Q3 		$2.5M Sell
64,563
-23,683
-27% -$950K 0.06% 184
2022
Q2 		$3.29M Sell
88,246
-490
-0.6% -$19.9K 0.09% 132
2022
Q1 		$3.93M Buy
+88,736
New +$3.85M 0.1% 118
2019
Q2 		– Sell
-68,767
Closed -$2.64M – 337
2019
Q1 		$2.64M Buy
+68,767
New +$2.63M 0.45% 41

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aptus Capital Advisors's BSX Position: Q2 2026 in Review

Aptus Capital Advisors reduced its Boston Scientific (BSX) stake by 23% in Q2 2026, selling an estimated $88.4K and leaving 5,594 shares worth $239K. The position accounts for ﹤0.01% of the portfolio, ranked #1043.

Aptus Capital Advisors first reported a position in BSX in Q1 2019 and has held it in 16 quarters since. The position peaked at $7.44M in Q4 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Aptus Capital Advisors held 5,594 shares of Boston Scientific worth $239K as of Q2 2026.
  • Aptus Capital Advisors sold 1,628 Boston Scientific shares in Q2 2026, an estimated $88.4K.
  • Boston Scientific made up ﹤0.01% of Aptus Capital Advisors's portfolio in Q2 2026, its #1043 holding.
  • Aptus Capital Advisors first reported a position in Boston Scientific in Q1 2019 and has held it in 16 quarters since.
  • Aptus Capital Advisors's Boston Scientific position peaked at $7.44M in Q4 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.